NCT06079892

Brief Summary

Triapedicular haemorroidectomy is currently the gold standard in haemorrhoidal pathology. Minimally invasive surgical techniques now play an important role in the haemorrhoidal management algorithm, particularly for less advanced stages of the disease. Among these techniques, radiofrequency is one of the most recent and is gradually gaining ground. It involves applying a radiofrequency current to the internal haemorrhoidal tissue in order to induce its involution. The literature has shown that this technique leads to symptomatic improvement in over 60% of cases and a high satisfaction rate, even though some patients still seem to have haemorrhoidal symptoms postoperatively. The aim of this study is to evaluate the efficacy of this technique in patients with haemorrhoidal pathology operated on at our centre, using "hard" criteria which are thought to be more rigorous ("cure" rather than "improvement").

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
80

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Mar 2017

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 1, 2017

Completed
6.6 years until next milestone

First Submitted

Initial submission to the registry

October 3, 2023

Completed
9 days until next milestone

First Posted

Study publicly available on registry

October 12, 2023

Completed
12 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 1, 2024

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

January 1, 2025

Completed
Last Updated

March 12, 2024

Status Verified

March 1, 2024

Enrollment Period

7.6 years

First QC Date

October 3, 2023

Last Update Submit

March 11, 2024

Conditions

Keywords

radiofrequency

Outcome Measures

Primary Outcomes (1)

  • Evaluation of radiofrequency treatment efficiency

    Assessement of the procedure efficiency on prolapsus (using Goligher Score) and bleeding (using Haemorrhoidal bleeding score). Procedure is considered efficient when Goligher Score =1 AND HBS = 0

    3 months post procedure

Secondary Outcomes (4)

  • Measurement of patient satisfaction after surgery

    3 months post procedure

  • Incidence rate of procedure complication

    3 months post procedure

  • description of procedure complication

    3 months post procedure

  • Identification of predictive factor for success

    3 months post procedure

Interventions

haemorrhoidal removal using radiofrequency

Eligibility Criteria

Age18 Years+
Sexall
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patient suffering for Haemorroidal pathology and requiring a removal procedure to whom a Radiofrequency procedure was performed

You may qualify if:

  • Age ≥ 18 years
  • Presence of haemorrhoidal pathology
  • Patient operated on between March 2017 and March 2023, using the radiofrequency technique
  • French-speaking patient

You may not qualify if:

  • ano-perineal involvement in Crohn's disease
  • perianal fistula
  • non-quiescent IBD
  • radiation-induced rectitis
  • psychiatric pathology.
  • under guardianship or curatorship
  • deprived of liberty
  • under court protection
  • Patient objecting to the use of his/her data for this research

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Fondation Hôpital Saint Joseph

Paris, 75014, France

RECRUITING

Central Study Contacts

Amine Antonin Alam, MD

CONTACT

Hélène BEAUSSIER, PharmaD, PhD

CONTACT

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

October 3, 2023

First Posted

October 12, 2023

Study Start

March 1, 2017

Primary Completion

October 1, 2024

Study Completion

January 1, 2025

Last Updated

March 12, 2024

Record last verified: 2024-03

Data Sharing

IPD Sharing
Will not share

Locations